Oxitec secures £8 million for dengue fever project

Venture-capital backed Oxitec Ltd of the UK has secured £8 million in new funding from a syndicate led by Oxford Capital Partners to finance further trials of a project designed to reduce populations of the mosquitoes that transmit dengue fever.